BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ayipo YO, Ahmad I, Najib YS, Sheu SK, Patel H, Mordi MN. Molecular modelling and structure-activity relationship of a natural derivative of o-hydroxybenzoate as a potent inhibitor of dual NSP3 and NSP12 of SARS-CoV-2: in silico study. J Biomol Struct Dyn 2022;:1-19. [PMID: 35037841 DOI: 10.1080/07391102.2022.2026818] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Farhan MM, Guma MA, Rabeea MA, Ahmad I, Patel H. Synthesizes, characterization, molecular docking and in vitro bioactivity study of new compounds containing triple beta lactam rings. Journal of Molecular Structure 2022;1269:133781. [DOI: 10.1016/j.molstruc.2022.133781] [Reference Citation Analysis]
2 Bouali N, Hammouda MB, Ahmad I, Ghannay S, Thouri A, Dbeibia A, Patel H, Hamadou WS, Hosni K, Snoussi M, Adnan M, Hassan MI, Noumi E, Aouadi K, Kadri A. Multifunctional Derivatives of Spiropyrrolidine Tethered Indeno-Quinoxaline Heterocyclic Hybrids as Potent Antimicrobial, Antioxidant and Antidiabetic Agents: Design, Synthesis, In Vitro and In Silico Approaches. Molecules 2022;27:7248. [DOI: 10.3390/molecules27217248] [Reference Citation Analysis]
3 Alsagaby SA, Iqbal D, Ahmad I, Patel H, Mir SA, Madkhali YA, Oyouni AAA, Hawsawi YM, Alhumaydhi FA, Alshehri B, Alturaiki W, Alanazi B, Mir MA, Al Abdulmonem W. In silico investigations identified Butyl Xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia. Sci Rep 2022;12:17648. [PMID: 36271116 DOI: 10.1038/s41598-022-21546-0] [Reference Citation Analysis]
4 Kalasariya HS, Patel NB, Gacem A, Alsufyani T, Reece LM, Yadav VK, Awwad NS, Ibrahium HA, Ahn Y, Yadav KK, Jeon BH. Marine Alga Ulva fasciata-Derived Molecules for the Potential Treatment of SARS-CoV-2: An In Silico Approach. Mar Drugs 2022;20:586. [PMID: 36135775 DOI: 10.3390/md20090586] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Radwan HA, Ahmad I, Othman IM, Gad-elkareem MA, Patel H, Aouadi K, Snoussi M, Kadri A. Design, synthesis, in vitro anticancer and antimicrobial evaluation, SAR analysis, molecular docking and dynamic simulation of new pyrazoles, triazoles and pyridazines based isoxazole. Journal of Molecular Structure 2022;1264:133312. [DOI: 10.1016/j.molstruc.2022.133312] [Reference Citation Analysis]
6 Kumar P, Pandey R, Dubey I, Ahmad I, Mahapatra DK, Patel H. In silico Study of Some Dexamethasone Analogs and Derivatives against SARs-CoV-2 Target: A Cost-effective Alternative to Remdesivir for Various COVID Phases. CCS 2022;2:294-309. [DOI: 10.2174/2210298102666220404102217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Bharadwaj KK, Ahmad I, Pati S, Ghosh A, Sarkar T, Rabha B, Patel H, Baishya D, Edinur HA, Abdul Kari Z, Ahmad Mohd Zain MR, Wan Rosli WI. Potent Bioactive Compounds From Seaweed Waste to Combat Cancer Through Bioinformatics Investigation. Front Nutr 2022;9:889276. [DOI: 10.3389/fnut.2022.889276] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]